Day: March 28, 2022

PLANO, Texas, March 28, 2022 (GLOBE NEWSWIRE) — European Wax Center, Inc. (NASDAQ:EWCZ) (together with its subsidiaries, the “Company”) today announced that it has priced $400 million of Series 2022-1 Class A-2 Fixed Rate Senior Secured Notes (the “Class A-2 Notes”) with an anticipated repayment term of five years, an aggregate principal amount of $400 million and a fixed interest rate of 5.50% per annum, payable quarterly. The Class A-2 Notes are expected to be issued by EWC Master Issuer LLC, a newly-formed, limited-purpose, bankruptcy remote indirect subsidiary of European Wax Center, Inc. in a privately placed securitization transaction. In addition to the Class A-2 Notes, the refinancing transaction is also expected to include a $40 million variable funding note facility (the “Variable Funding Notes”). As of the closing, none...

NEW YORK, March 28, 2022 (GLOBE NEWSWIRE) — Woodgrain Inc. (“Parent”) announced today that its affiliate, HBP Merger Sub, Inc. (“Purchaser”), commenced the previously announced cash tender offer for all of the issued and outstanding shares of Common Stock (the “Shares”) of Huttig Building Products, Inc. (Nasdaq: HBP) (“Huttig”) at a price of $10.70 per share, net to the seller, in cash, without interest and less applicable withholding taxes. The tender offer is being made pursuant to the merger agreement (the “Merger Agreement”) executed on March 20, 2022 and announced by Woodgrain and Huttig on March 21, 2022. The $10.70 per share all-cash tender offer is being made pursuant to an Offer to Purchase dated March 28, 2022, and represents a premium of approximately 12.6% over Huttig’s closing share price on March 21, 2022, the last...

VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) — Abacus Mining & Exploration Corporation (“Abacus” or the “Company”) (TSXV:AME) is pleased to announce that the Board of Directors has approved the grant of stock options to directors, officers, employees and consultants of the Company allowing for the acquisition of up to, in the aggregate, 3,050,000 shares of the Company. The grant is a result of the Company’s annual compensation review and the issuance is made under the Company’s approved stock option plan. The options are exercisable at a price of $0.07 per share for a period of five years from the date of grant and are subject to regulatory policies. On Behalf of the Board,ABACUS MINING & EXPLORATION CORPORATION Paul G. Anderson, P.Geo.President and CEO About AbacusAbacus is a mineral exploration and mine...

CALGARY, Alberta, March 28, 2022 (GLOBE NEWSWIRE) — Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to announce the most recent version of the Company’s monthly activity update can be found on the Company’s website at https://www.petrusresources.com/monthlyupdates. Additionally, further to the fully backstopped rights offering previously announced on March 24, 2022, the Company has posted instructions for Petrus shareholders wishing to subscribe to the offering. The directions can be found on the Company’s website at https://www.petrusresources.com/investor-relations. Any questions related to the rights offering can be directed to Odyssey Trust Company at (587) 885-0960 or 1 (888) 290-1175. ABOUT PETRUSPetrus is a public Canadian oil and gas company focused on property exploitation, strategic acquisitions...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. MONTREAL, March 28, 2022 (GLOBE NEWSWIRE) — MONARCH MINING CORPORATION (“Monarch” or the “Corporation”) (TSX: GBAR) (OTCQX: GBARF) is pleased to announce that it has received shareholder approval by written resolution for the private placement announced on March 16, 2022. The terms of the private placement, as announced in the March 16 press releases, and the process for obtaining shareholder approval are described below. The Corporation intends to complete a brokered private placement for the issuance and sale of 20,000,000 units of the Corporation (the “Units”) at a price of $0.60 per Unit (the “Subscription Price”), for aggregate gross proceeds of...

MONACO, March 28, 2022 (GLOBE NEWSWIRE) — Costamare Inc. (the “Company” or “our”) (NYSE: CMRE) announced today that its Annual Report on Form 20-F for the fiscal year ended December 31, 2021 (the “Annual Report”) has been filed with the U.S. Securities and Exchange Commission and can be accessed on the Company’s website, www.costamare.com, in the “Investors” section under “Annual Reports”. Stockholders may also request a hard copy of the Annual Report, which includes the Company’s complete 2021 audited financial statements, free of charge, by contacting the Company’s investor relations manager at ir@costamare.com. About Costamare Inc. Costamare Inc. is one of the world’s leading owners and providers of containerships for charter. The Company has 48 years of history in the international shipping industry and a fleet of 82 containerships,...

Bagsværd, Denmark, 28 March 2022 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a 2.0 mg dose of Ozempic® (once-weekly semaglutide subcutaneous injection), a glucagon-like peptide-1 (GLP-1) analogue for the treatment of adults with type 2 diabetes. Ozempic® is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults. Further, Ozempic® is indicated to reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes and known heart disease. The FDA approval is based on the results from the SUSTAIN FORTE trial. In the trial, people treated with semaglutide 2.0 mg achieved a statistically significant and superior reduction in HbA1c at week 40 compared to semaglutide 1.0 mg. In the trial, both doses of...